title: Reestimation of the effects of inorganic phosphates on the equilibrium between oxygen and hemoglobin.
abstract: In a previous paper, published in this journal, we showed that the data obtained in patients with severe ketoacidosis suggest that inorganic phosphates (K2HPO4) can increase their P50 and therefore enhance tissue oxygenation without concomitant alteration of the 2,3 diphosphoglycerate (DPG). In order to test the hypothesis that K2HPO4 could influence the oxyhemoglobin dissociation curve (ODC) by a mecanism which was not DPG mediated we have measured the total ODC on whole blood with and without addition of 13-80 mmol/l of inorganic phosphates. On average, the level of DPG remained unchanged when the P50 with K2HPO4 was significantly higher (p greater than 0.001) (P50 = 29.9 +/- 3.7 mmHg) than when phosphates were not administered (P50 = 25.5 +/- 2.8 mmHg). The relationship between P50 (mmHg) and K2HPO4 (= X mmol/l) was delta P50 = -2.97 10(-3)(X)2 +0.26(X)-0.42 (r = 0.78). Seeing that phosphates have an immediate action on the ODC, we calculated in our ketoacidosis patients, the relationship between the P50, the inorganic phosphates (P(i) in mg%) and the DPG in mumol/gHb. Both factors exert a highly significant effect (p less than 0.001) on the P50, according to the following equation: P50 = 0.35 DPG +0.26 P(i) + 18.92 (r = 0.73). Our data are important in two points. First it is useful to add inorganic phosphates to the treatment of patients with severe ketoacidosis in order to enhance their tissue oxygenation. Second they recall that the ODC is not only determined by the classical effects of temperature, pH and DPG but also by inorganic anions, like phosphates as described by Benesh and Benesh in their pioneering work.
authors.affiliation: Department of Internal Medicine, Cliniques Universitaries St Luc, Brussels, Belgium.
authors.forename: T
authors.initials: T
authors.lastname: Clerbaux
authors.forename: B
authors.initials: B
authors.lastname: Detry
authors.forename: M
authors.initials: M
authors.lastname: Reynaert
authors.forename: F
authors.initials: F
authors.lastname: Kreuzer
authors.forename: A
authors.initials: A
authors.lastname: Frans
mesh_terms: D019794:2,3-Diphosphoglycerate; D001784:Blood Gas Analysis; D016883:Diabetic Ketoacidosis / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D004163:Diphosphoglyceric Acids / Q000097:blood / Q000378:metabolism*; D005069:Evaluation Studies as Topic; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010101:Oxygen Consumption / Q000502:physiology*; D010108:Oxyhemoglobins / Q000032:analysis / Q000378:metabolism*; D010710:Phosphates / Q000097:blood / Q000502:physiology* / Q000627:therapeutic use; D010758:Phosphorus / Q000172:deficiency
chemical_list: D004163:Diphosphoglyceric Acids; D010108:Oxyhemoglobins; D010710:Phosphates; D019794:2,3-Diphosphoglycerate; D010758:Phosphorus